
SynBioBeta 2026 Speaker
Rimma Boshernitsan
DIALOGUE
CEO, Futurist, Strategist
Rimma Boshernitsan is a futurist, strategist, and the founder and CEO of DIALOGUE, an interdisciplinary strategic advisory that helps leaders stop reacting to the zeitgeistโand start shaping it. Over the course of a 20-year career, she has served as a strategic advisor and thought partner to CEOs of emerging businesses and Fortune 500 organizations, including Apple, Tata, Roche, Google, Kaiser Permanente, Aesop, Leviโs, Lyft, Kraft Foods, and Chevron. She has worked internationally, including in Moscow, London, and throughout the U.S.Rimma began her career at Deloitte Consultingโs Human Capital practice, where she focused on M&A and large-scale transformation, before moving into in-house advisory work across healthcare, consumer business, and telecommunications. A period advising contemporary art collectors sharpened her sensitivity to how cultural, political, and scientific shifts often emerge at the edges of institutions before becoming strategic imperatives within them. That insight led her to found DIALOGUE.At the center of Rimmaโs work is a model she calls the Triad of Intelligences: human intelligence, machine intelligence, and planetary intelligence. Her work on co-intelligence is not in biotech itself, but adjacent and highly relevant to itโfocused on how societies, institutions, and leaders make wiser decisions about health, healthspan, longevity, and the conditions that allow life to flourish. She explores how human intuition, ethical judgment, and living systems awareness must evolve alongside technical capability if innovation is to remain coherent, evidence-based, and humane. In her recent work, including her Noema essay and talks on a planetary nervous system, she argues that health is not only a clinical question, but a systems question. ๏ฟผ ๏ฟผRimmaโs expertise moves across strategic foresight, AI transformation, and co-intelligent leadership. She has spoken and moderated at SXSW, the Swiss Consulate, WRLDCTY, and other public forums, and is known for guiding conversations that connect frontier innovation to its broader human, ethical, and societal implications. At SynBioBeta, she brings an interdisciplinary lens to the frontier of longevity scienceโfocused less on the lab itself than on the larger questions of judgment, coherence, healthspan, and human consequence that emerge around it.



Reagan
Jarvis
Anocca AB
CEO, Co-founder

Alex
Rives
CZI Biohub
Head of Science

Karenโฏ
Akinsanya
Schrodinger
President, R&D โ Therapeutics

Christopher
Arendt
Takeda
CSO, Head of Research

Stef
van Grieken
Cradle
CEO

Michael
Koeris
DARPA
Director, BTO

Jennifer
Dionne
Pumpkinseed
CEO

Daniyal
Hussain
GSK
Exec. Dir., Tech BD

Cynthia
Hong
Novartis
Dir., Search & Evaluation
SynBioBeta 2027 May 3-6, San Jose, California


